Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-12-10
1981-09-15
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
564282, 564284, 564287, 564289, A61K 3114, C07C 8500, C07C 8700, C07C 9300
Patent
active
042897874
ABSTRACT:
Quaternary ammonium salts of certain phenylbutylamines are useful antiarrhythmic drugs. A method for treating arrhythmia and prolonging the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such quaternary ammonium salts are disclosed.
REFERENCES:
patent: 2884436 (1959-04-01), Janssen et al.
patent: 3972935 (1976-08-01), Molloy
patent: 4001433 (1977-01-01), Maxwell et al.
patent: 4034011 (1977-07-01), Molloy
Pharmac 37, 555-584, 1969--Barlow et al.
European J. of Pharm. 35 (1976), 245-252--Lien et al.
Chem. Abst. 54, 19588(f) (1960)--Morikawa.
Molloy Bryan B.
Steinberg Mitchell I.
Ashbrook Charles W.
Eli Lilly and Company
Robinson Douglas W.
Whale Arthur R.
LandOfFree
Quaternary ammonium antiarrhythmic drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quaternary ammonium antiarrhythmic drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quaternary ammonium antiarrhythmic drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391146